Overview

• Indira IVF has confidentially submitted a draft red herring prospectus to SEBI and stock exchanges as the first step in its revived IPO process.
• Existing shareholders plan to sell stakes worth about 35 billion rupees, with EQT offloading roughly 29 billion rupees and three Murdia family members selling about 2 billion rupees apiece.
• Offered shares will carry a face value of ₹5 each and are proposed to list on the main boards of both the National Stock Exchange and Bombay Stock Exchange.
• The new filing follows a March withdrawal of its initial draft after SEBI scrutiny linked to a Bollywood biopic on founder Ajay Murdia, though the company maintained the regulator did not direct the pullback.
• Market sources say peers Gaudium IVF and Women Health are preparing to refile IPO papers, reflecting rising investor interest in India’s fertility and women’s health sector.